Journal of Oral and Maxillofacial Surgery
Volume 66, Issue 8 , Pages 1644-1651 , August 2008

Effect of Botulinum Toxin-A in Myofascial Pain Patients With or Without Functional Disc Displacement

  • Cem Kurtoglu, DDS, PhD

      Affiliations

    • Assistant Professor, Department of Prosthodontics, Faculty of Dentistry, University of Cukurova, Adana, Turkey.
    • ,
  • Osman Hayri Gur, DDS, PhD

      Affiliations

    • Formerly, Department of Prosthodontics, Faculty of Dentistry; and Currently, Private Practice, Adana, Turkey.
    • ,
  • Mehmet Kurkcu, DDS, MSc, PhD

      Affiliations

    • Associate Professor, Department of Oral Surgery, Faculty of Dentistry, University of Cukurova, Adana, Turkey.
    • Corresponding Author InformationAddress correspondence and reprint requests to Dr Kurkcu: Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, University of Cukurova, 01130 Balcali, Adana, Turkey
    • ,
  • Yasar Sertdemir, PhD

      Affiliations

    • Instructor, Department of Biostatistics, Faculty of Medicine, University of Cukurova, Adana, Turkey.
    • ,
  • Fusun Guler-Uysal, MD

      Affiliations

    • Professor, Department of Physical and Rehabilitation Medicine, Faculty of Medicine, University of Cukurova, Adana, Turkey.
    • ,
  • Hakan Uysal, DDS, PhD

      Affiliations

    • Professor, Department of Prosthodontics, Faculty of Dentistry, University of Cukurova, Adana, Turkey.

References 

  1. Okeson JP. Orofacial Pain: Guidelines for Assessment, Diagnosis and Management. In: Chicago: Quintessence Co; 1996;p. 45–52
  2. Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: Review, criteria, examinations and specifications, critique. J Craniomandib Disord Facial Oral Pain. 1992;6:301
  3. Davies SJ, Gray RJ. The pattern of splint usage in the management of two common temporomandibular disorders (Part II: The stabilisation splint in the treatment of pain dysfunction syndrome). Br Dent J. 1997;183:247
  4. Garefis P, Grigoriadou E, Zarifi A, et al. Effectiveness of conservative treatment for craniomandibular disorders: A 2-year longtidunal study. J Orofac Pain. 1994;8:309
  5. Bentsianov B, Zalvan C, Blitzer A. Noncosmetic uses of botulinum toxin. Clin Dermatol. 2004;22:82
  6. Poewe W, Deuschl G, Nebe A, et al. What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia: Results of a double blind, placebo controlled, dose ranging study using Dysport (The German Dystonia Study Group—GDSG). J Neurol Neurosurg Psychiatry. 1998;64:13
  7. Freund B, Schwartz M, Symington JM. Botulinum toxin: New treatment for temporomandibular disorders. Br J Oral Maxillofac Surg. 2000;38:466
  8. Freund B, Schwartz M, Symington JM. The use of botulinum toxin for the treatment of temporomandibular disorders: Preliminary findings. J Oral Maxillofac Surg. 1999;57:916
  9. Tan EK, Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc. 2000;131:211
  10. To EW, Ahuja AT, Ho WS. A prospective study of the effect of botulinum toxin on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg. 2001;54:197
  11. Altman DG, Schulz KF, Moher D, et al. CONSORT Group (Consolidated Standards of Reporting Trials) The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med. 2001;134:663
  12. Landulpho AB, Silva WA, Silva FA, et al. Electromyographic evaluation of masseter and anterior temporalis muscles in patients with temporomandibular disorders following interocclusal appliance treatment. J Oral Rehabil. 2004;31:95
  13. Schwartz M, Freund B. Treatment of temporomandibular disorders with botulinum toxin. Clin J Pain. 2002;18:198
  14. LeResche L. Assessment of physical and behavioral outcomes of treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83:82
  15. Okeson JP. Management of Temporomandibular Disorders and Occlusion. ed 5. St Louis, MO: Mosby; 2003;
  16. Pullman SL, Goodin DS, Marquinez AI, et al. Clinical utility of surface EMG: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2000;55:171
  17. Cooper BC. The role of bioelectronic instrumentation in the documentation and management of temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83:91
  18. Lund JP, Widmer CG. Evaluation of the use of surface electromyography in the diagnosis, documentation and treatment of dental patients. J Craniomandib Disord. 1989;3:125
  19. Manns A, Miralles R, Guerrer F. The changes in electrical activity of the postural muscles of mandible upon varying the vertical dimension. J Prosthet Dent. 1981;45:438
  20. Watkinson AC. The mandibular rest position and electromyography—A review. J Oral Rehabil. 1987;14:209
  21. Mohamed SE, Christensen LV. Mandibular reference positions. J Oral Rehabil. 1985;12:355
  22. Mohl ND, Lund JP, Widmer CG, et al. Devices for the diagnosis and treatment of temporomandibular disorders (Part II: Electromyography and sonography). J Prosthet Dent. 1990;63:332
  23. Nixdorf DR, Heo G, Major PW. Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain. Pain. 2002;99:465
  24. Holmgren K, Sheikholeslam A, Riise C, et al. The effects of an occlusal splint on the electromyographic activities of the temporal and masseter muscles during maximal clenching in patients with a habit of nocturnal bruxism and signs and symptoms of craniomandibular disorders. J Oral Rehabil. 1990;17:447
  25. Abekura H, Kotani H, Tokuyama H, et al. Asymmetry of masticatory muscle activity during intercuspal maximal clenching in healthy subjects and subjects with stomatognathic dysfunction syndrome. J Oral Rehabil. 1995;22:699
  26. Tesch RS, Denardin OV, Baptista CA, et al. Depression levels in chronic pain patients: A pilot study. J Oral Rehabil. 2004;31:926
  27. Conti PC, de Azevedo LR, de Souza NV, et al. Pain measurement in TMD patients: Evaluation of precision and sensitivity of different scales. J Oral Rehabil. 2001;28:534
  28. Dworkin SF. A model for pain mechanisms in myogenous temporomandibular disorders. Pain Forum. 1997;6:166
  29. Freund B, Schwartz M. Temporal relationship of muscle weakness and pain reduction in subjects treated with botulinum toxin A. J Pain. 2003;4:159
  30. von Lindern JJ, Niederhagen B, Berge S, et al. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. J Oral Maxillofac Surg. 2003;61:774

 Supported by grant DHF 2004 D-1 from the University of Cukurova Fund.

PII: S0278-2391(08)00364-9

doi: 10.1016/j.joms.2008.03.008

Journal of Oral and Maxillofacial Surgery
Volume 66, Issue 8 , Pages 1644-1651 , August 2008

Article Tools